Advanced Search

ICD-10-PCS code List for Other Hormone

ICD-10-PCS code List for Other Hormone is medical classification list by Centers for Medicare and Medicaid Services (CMS).

PCS Tables

PCS CODE

Description

Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Other Gas into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Destructive Agent into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach

Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Endoscopic Approach

Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic